Heron Therapeutics (HRTX) Cash from Operations (2010 - 2026)
Heron Therapeutics (HRTX) reported Cash from Operations of 1540000.0 for Q1 2026, up 82.64% on a YoY basis from 843197.53 in Q1 2025, and up 83.23% quarter-over-quarter from 9184000.0 in Q4 2025.
Heron Therapeutics (HRTX) Cash from Operations (2010 - 2026) Analysis & Trends
Heron Therapeutics has reported Cash from Operations for 17 years, with the latest figure at 1540000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 82.64% year-over-year to 1540000.0; the trailing twelve-month figure through Mar 2026 stood at 20261000.0 (up 7.41% YoY), and the FY2025 full-year result was 27591000.0, down 22.47% from the prior year.
- Cash from Operations for Q1 2026 stood at 1540000.0, up from 9184000.0 in the prior quarter.
- The five-year high for Cash from Operations was 3371000.0 in Q3 2024, with the low at 43939000.0 in Q1 2022.
- Historically, Cash from Operations has averaged 15138882.35 across 5 years, with a median of 9516000.0 in 2024.
- The largest YoY upside for Cash from Operations was 136.73% in 2024 against a maximum downside of 579.84% in 2024.
- Heron Therapeutics' Cash from Operations stood at 37534000.0 in 2022, then soared by 106.54% to 2455000.0 in 2023, then slumped by 579.84% to 11780000.0 in 2024, then grew by 22.04% to 9184000.0 in 2025, then jumped by 83.23% to 1540000.0 in 2026.
- The last three Cash from Operations figures came in at 1540000.0 (Q1 2026), 9184000.0 (Q4 2025), and 1331000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Heron Therapeutics | 76.81 Mn | 46.84 Mn | 24.07 Mn | -1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.54 Mn |
| Mar 31, 2026 | -1.54 Mn |
| Dec 31, 2025 | -9.18 Mn |
| Dec 31, 2025 | -9.18 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | -10.87 Mn |
| Jun 30, 2025 | -10.87 Mn |
| Mar 31, 2025 | -8.87 Mn |
| Mar 31, 2025 | -8.87 Mn |
| Dec 31, 2024 | -11.78 Mn |
| Dec 31, 2024 | -11.78 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | -4.60 Mn |
| Jun 30, 2024 | -4.60 Mn |
| Mar 31, 2024 | -9.52 Mn |
| Mar 31, 2024 | -9.52 Mn |
| Dec 31, 2023 | 2.46 Mn |
| Dec 31, 2023 | 2.46 Mn |